Traumatic Brain Injury (TBI) Treatment Adv Tech

Abstract

This Project covers development, demonstration, and transition of technologies for acute battlefield management of Traumatic Brain Injury (TBI). Efforts include pre-clinical demonstration of drug therapy and resuscitation strategies for treatment of acute TBI in the pre-hospital setting, biomarkers, diagnostics, and devices, as well as novel drug delivery technologies to facilitate administration of pharmaceuticals at or near the point of injury to protect the injured brain from further damage. All research is conducted in compliance with Food and Drug Administration (FDA) requirements for licensure of medical products for human use. Promising efforts identified through Applied Research conducted under PE 0602787A, Project MM4 are further matured under this Project. Promising results identified under this Project are further matured under PE 0603807A, Project 836. The cited work is consistent with the Under Secretary of Defense (Research and Engineering) science and technology focus areas and the Army Modernization Strategy. Work in this Project is performed by: the U.S. Army Medical Research Materiel Command (USAMRMC), Fort Detrick, MD..

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2020
Source ID
MO2_0603002A_3_2040_PB_2020

Tags

Fields of Study

  • Medicine

Readers

  • Military Science and Technology Research and Modernization.
  • Trauma or Military Medicine
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.

Related Documents